STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

22nd Century Group to Announce Third Quarter 2025 Results on November 4, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

22nd Century Group (Nasdaq: XXII) will report third quarter 2025 results on November 4, 2025. The company will issue a press release at 6:00 AM ET and host a live webcast at 8:00 AM ET with CEO Larry Firestone and CFO Dan Otto reviewing financial results, recent progress, and 2025 plans.

The company highlights its VLN® combustible cigarette containing 95% less nicotine and notes VLN® is the only low‑nicotine combustible cigarette authorized by the FDA in the U.S. Investors can access the live and archived webcast via the company Events page at https://ir.xxiicentury.com/events.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-1.95% News Effect

On the day this news was published, XXII declined 1.95%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

MOCKSVILLE, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, will host a webcast on Tuesday, November 4, 2025, at 8:00 AM ET to discuss its 2025 third quarter results, which are to be reported in a press release at 6:00 AM ET the same day.

During the webcast, Larry Firestone, chairman and chief executive officer, and Dan Otto, chief financial officer, will review financial results, discuss progress made in the recent months and update plans for the 2025 year.

The live and archived webcast will be accessible on the Events web page in the Company's Investor Relations section of the website, at https://ir.xxiicentury.com/events. Please access the website at least 10 minutes prior to the start of the webcast to register and, if necessary, download and install any required software.

About 22nd Century Group, Inc.

22nd Century Group is pioneering the tobacco harm reduction movement by enabling smokers to take control of their nicotine consumption.

Our Technology is Tobacco

Our proprietary non-GMO reduced nicotine tobacco plants were developed using our patented technologies that regulate alkaloid biosynthesis activities resulting in a tobacco plant that contains 95% less nicotine than traditional tobacco plants. Our extensive patent portfolio has been developed to ensure that our high-quality tobacco can be grown commercially at scale. We continue to develop our intellectual property to ensure our ongoing leadership in the tobacco harm reduction movement.

Our Products

We created our flagship product, the VLN® cigarette using our low nicotine tobacco, to give traditional cigarette smokers an authentic and familiar alternative in the form of a combustible cigarette that helps them take control of their nicotine consumption. VLN® cigarettes have 95% less nicotine compared to traditional cigarettes and have been proven to allow consumers to greatly reduce their nicotine consumption.

FDA Authorized

Our VLN® cigarette is the only low nicotine combustible cigarette authorized by the FDA in the United States.

VLN® is a registered trademark of 22nd Century Limited LLC.

Learn more at xxiicentury.com, on X (formerly Twitter), on LinkedIn, and on YouTube.

Learn more about VLN® at tryvln.com.

Cautionary Note Regarding Forward-Looking Statements

Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements, including but not limited to our full year business outlook. Forward-looking statements typically contain terms such as “anticipate,” “believe,” “consider,” “continue,” “could,” “estimate,” “expect,” “explore,” “foresee,” “goal,” “guidance,” “intend,” “likely,” “may,” “plan,” “potential,” “predict,” “preliminary,” “probable,” “project,” “promising,” “seek,” “should,” “will,” “would,” and similar expressions. Forward-looking statements include, but are not limited to, statements regarding (i) our cost reduction initiatives, (ii) our expectations regarding regulatory enforcement, including our ability to receive an exemption from new regulations, (iii) our financial and operating performance and (iv) our expectations for our business interruption insurance claim. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in “Risk Factors” in the Company’s Annual Report on Form 10-K filed on March 20, 2025 and Quarterly Reports on Form 10-Q on May 13, 2025 and August 14, 2025. All information provided in this release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law.

Investor Relations & Media Contact
Matt Kreps
Investor Relations
22nd Century Group
investorrelations@xxiicentury.com
214-597-8200


FAQ

When will 22nd Century Group (XXII) release Q3 2025 results?

The company will release its Q3 2025 press release on November 4, 2025 at 6:00 AM ET.

What time is the 22nd Century Group (XXII) webcast to discuss Q3 2025 results?

The live webcast is scheduled for November 4, 2025 at 8:00 AM ET and will be archived online.

Who will present 22nd Century Group's (XXII) Q3 2025 webcast?

CEO Larry Firestone and CFO Dan Otto will review financial results and company progress during the webcast.

Where can investors access the 22nd Century Group (XXII) Q3 2025 webcast?

Access the live and archived webcast at the company's Events page: https://ir.xxiicentury.com/events.

What key product information did 22nd Century Group (XXII) highlight ahead of Q3 2025 results?

The company notes its VLN® cigarette contains 95% less nicotine and is the only low‑nicotine combustible cigarette authorized by the FDA in the U.S.
22Nd Century

NASDAQ:XXII

XXII Rankings

XXII Latest News

XXII Latest SEC Filings

XXII Stock Data

7.34M
6.68M
1.91%
0.88%
2.77%
Tobacco
Cigarettes
Link
United States
WILLIAMSVILLE